Market Value697,057,805
Total Holdings72
File Date2023-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
BLI / Berkeley Lights Inc
CSTL / Castle Biosciences, Inc.
RNA / Avidity Biosciences, Inc.
NTRA / Natera, Inc.
NEOG / Neogen Corporation
KRYS / Krystal Biotech, Inc.
STAA / STAAR Surgical Company
KROS / Keros Therapeutics, Inc.
TXG / 10x Genomics, Inc.
ENOV / Enovis Corporation
CCCC / C4 Therapeutics, Inc.
LLY / Eli Lilly and Company
DALS / DA32 Life Science Tech Acquisition Corp - Class A
KDNY / Chinook Therapeutics Inc
AMLX / Amylyx Pharmaceuticals, Inc.
PARDES BIOSCIENCES INC / (69945Q105)
EIGR / Eiger BioPharmaceuticals, Inc.
/ VENTYX BIOSCIENCES INC
RXDX / Prometheus Biosciences Inc
NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)
XLO / Xilio Therapeutics, Inc.
OFIX / Orthofix Medical Inc.
NPCE / NeuroPace, Inc.
NRIX / Nurix Therapeutics, Inc.
AXGN / Axogen, Inc.
EDAP / EDAP TMS S.A. - Depositary Receipt (Common Stock)
LUNG / Pulmonx Corporation
THTX / Theratechnologies Inc.
NVRO / Nevro Corp.
INMD / InMode Ltd.
IOBT / IO Biotech, Inc.
ILMN / Illumina, Inc.
FGEN / FibroGen, Inc.
TMDX / TransMedics Group, Inc.
TGTX / TG Therapeutics, Inc.
CVS / CVS Health Corporation
PIRS / Pieris Pharmaceuticals, Inc.
OSUR / OraSure Technologies, Inc.
KIDS / OrthoPediatrics Corp.
APLS / Apellis Pharmaceuticals, Inc.
BIIB / Biogen Inc.
INBX / Inhibrx Biosciences, Inc.
AVTE / Aerovate Therapeutics, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
ISEE / IVERIC bio Inc
VSTM / Verastem, Inc.
ADVM / Adverum Biotechnologies, Inc.
CUTR / Cutera, Inc.
APEN / Apollo Endosurgery Inc
HCA / HCA Healthcare, Inc.
PEPG / PepGen Inc.
DXCM / DexCom, Inc.
ISRG / Intuitive Surgical, Inc.
IMGO / Imago BioSciences Inc
PHVS / Pharvaris N.V.
HUM / Humana Inc.
IRMD / IRADIMED CORPORATION
CVRX / CVRx, Inc.
NARI / Inari Medical, Inc.
MIRM / Mirum Pharmaceuticals, Inc.
DICE / DICE Therapeutics Inc
PLRX / Pliant Therapeutics, Inc.
FDMT / 4D Molecular Therapeutics, Inc.
CRSP / CRISPR Therapeutics AG
NVST / Envista Holdings Corporation
UTHR / United Therapeutics Corporation
INSP / Inspire Medical Systems, Inc.
AXSM / Axsome Therapeutics, Inc.
VCEL / Vericel Corporation
TNDM / Tandem Diabetes Care, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
ANAB / AnaptysBio, Inc.
ESTA / Establishment Labs Holdings Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
ORGO / Organogenesis Holdings Inc.
SRDX / Surmodics, Inc.
BCAB / BioAtla, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
EPIX / ESSA Pharma Inc.
ETNB / 89bio, Inc.
ENTA / Enanta Pharmaceuticals, Inc.
EXAS / Exact Sciences Corporation
CRL / Charles River Laboratories International, Inc.
PTGX / Protagonist Therapeutics, Inc.
CELC / Celcuity Inc.
IOVA / Iovance Biotherapeutics, Inc.
ACLX / Arcellx, Inc.
PCVX / Vaxcyte, Inc.
VRDN / Viridian Therapeutics, Inc.
XENE / Xenon Pharmaceuticals Inc.
SKIN / The Beauty Health Company
FATE / Fate Therapeutics, Inc.
LYRA / Lyra Therapeutics, Inc.
YMAB / Y-mAbs Therapeutics, Inc.
PEN / Penumbra, Inc.
IMUX / Immunic, Inc.